Mufin Green Finance Limited Overview
| Field | Detail |
|---|---|
| Current legal name | Mufin Green Finance Limited ("MGFL") |
| Former name | APM Finvest Limited (May 2016 – mid-2022) |
| Date of name change | 15 July 2022 per most CMOTS-derived profiles; one CMOTS table records 11 June 2022 (discrepancy noted) [Src: Arihant Capital/CMOTS company profile and name-change table] |
| Incorporation | 13 May 2016, State of Rajasthan, as a public limited company [Src: CMOTS profile; BSE filings] |
| Original CIN | L65990RJ2016PLC054921 (Rajasthan) [Src: BSE filings 2020–2022] |
| Current CIN | L65990DL2016PLC447681. The "DL" code indicates the registered office has moved to Delhi [Src: Tracxn legal-entity record, 2026] |
| Original registered office | SP-147, RIICO Industrial Area, Bhiwadi, District Alwar, Rajasthan 301019 |
| Current HQ / corporate office | 201–202, 2nd Floor, Best Sky Tower, Netaji Subhash Place, Pitampura, New Delhi 110034 [Src: BSE filing May 2022; Morningstar; BRSR FY2024] |
| Regulatory status | RBI-registered Non-Banking Financial Company, Non-Deposit Taking (NBFC-ND). Registered with RBI's Jaipur Regional Office on 16 Feb 2017 [Src: company "About" text via InvestYadnya] |
| Listing – BSE | Scrip code 542774 (symbol now MUFIN). Listed September 2019 after the demerger [Src: Simply Wall St listing record; BSE] |
| Listing – NSE | Symbol MUFIN, listed 6 November 2023 (initially in the BE series) [Src: NSE letter NSE/LIST/136 dated 2 Nov 2023; NSE circular 3 Nov 2023] |
| ISIN | INE08KJ01020 (current). The earlier ISIN INE08KJ01012 applied before the face-value change [Src: CMOTS; BSE Form C filing Dec 2020] |
| CUSIP | Not applicable (no US listing) |
| Face value | ₹1 per share (current); ₹2 at the original 2019 allotment |
| Shares outstanding | ~19.82 Cr after the March 2026 preferential allotment, before later warrant and ESOP conversions [Src: allotment filing 4 Mar 2026] |
| Fiscal year end | 31 March |
| Statutory auditor | M/s Gaur & Associates, Chartered Accountants. Appointed 28 Aug 2025 to fill the casual vacancy left by the resignation of M/s Tattvam & Co.; term FY2025–28, subject to AGM approval [Src: Board outcome 28 Aug 2025] |
| Secretarial auditor | M/s Abhay K & Associates (FY2025–30) [Src: same] |
| Parent / promoter | Hindon Mercantile Limited (Mufin Group) together with Kapil Garg and family [Src: Acuité rationales; CMOTS] |
| Employees | 481 (BRSR FY2024); ~537 (third-party, FY2025); management targets ~300 (FY2026 call commentary) — see trend table below |
| Market capitalisation | ~₹2,797 Cr at ₹141/share (19 Oct 2026, NSE/BSE close) [Src: Screener.in, 19 Oct 2026] |
| Website | www.mufingreenfinance.com (legacy www.apmfinvest.com still referenced on aggregators) |
The entity in the source list, APM Finvest Limited (BSE: 542774, "APMFINVEST.BO"), still exists as the same legal entity but has been renamed Mufin Green Finance Limited. Control passed from the Rajgarhia family (APM Industries group) to Hindon Mercantile Limited and Mr. Kapil Garg in March 2022. The renaming followed in mid-2022.
| Metric | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
| Total employees (number) | 481 | 537 | — |
Notes: FY2024 is from the company's BRSR (421 male, 60 female) [Src: BRSR FY2023-24]. The FY2025 figure is a third-party estimate [Src: Musaffa, Dec 2025]. A FY2026 closing headcount is not publicly disclosed in the sources reviewed. Company materials cite a 15.83% workforce reduction across the four quarters of FY2026 [Src: Q4 FY26 investor presentation], and a 26.45% headcount reduction against 6.9x disbursement growth over a longer period, with a stated goal of ~300 employees [Src: Tickertape summary of FY26 call]. Blank = not publicly disclosed.
Mufin Green Finance is a New Delhi-based, RBI-registered NBFC-ND listed on NSE and BSE. It occupies the shell of the former APM Finvest, the investment-company demerger vehicle of APM Industries. After Kapil Garg's Mufin Group took control in March 2022, the company was repositioned as what it calls India's first listed NBFC dedicated to electric-vehicle (EV) and climate finance. It lent against e-rickshaws, electric two- and three-wheelers, chargers, swappable batteries and later solar assets. Since FY2026 the strategy has pivoted sharply toward fully digital, low-touch retail credit: mediclaim (health-insurance) premium financing through 10+ insurer integrations, and "Salary Saathi" payroll-linked loans to government employees. Climate lending and secured MSME loans remain important but are declining as a share of the book. AUM reached ₹1,599 Cr in June 2026, up 69% YoY. Management guides to ₹2,500 Cr AUM and ₹80–90 Cr PAT for FY2027. The equity trades at a steep premium to book (~4.9x), so the investment case depends on whether the mediclaim pivot delivers both scale and quality.
What the company does
| Vertical (as reported) | AUM INR Cr (30 Jun 2026) | Share of AUM | Character |
|---|---|---|---|
| Mediclaim Financing | 676.61 | 42% | Converts lump-sum health-insurance premiums into EMIs at point of sale via insurer integrations; fully digital, no branches |
| Other Loans (MSME & corporate) | 458.84 | 29% | Collateral-backed loans to MSMEs and corporates; management says 100% collateral-backed |
| Climate Financing (EV & Solar) | 410.83 | 26% | Loans and leases for EVs (2W/3W/4W), chargers, swappable batteries and solar; company cites IoT-backed asset monitoring |
| Salary Saathi | 52.97 | 3% | Payroll-linked personal loans to government and PSU employees; management claims near-zero default risk because repayment comes via payroll |
| Total AUM | 1,599.23 | 100% | — |
MGFL is a balance-sheet lender. It borrows from banks, NBFCs, development finance institutions (DFIs), NCD investors and offshore bond investors. It then on-lends to retail and small-business borrowers, earning a net interest spread plus processing and other fees. As of Q1 FY2027 (June 2026) the loan book had four reported verticals [Src: Q1 FY27 investor update; ScanX/Multibagg summaries, Aug 2026]:
Note: the sum of the four verticals (1,599.25) matches reported total AUM (1,599.23) within rounding (computed).
Business and revenue model
Revenue model: About 99% interest income on loans and leases. Revenue from operations was ₹210.29 Cr in FY2026 [Src: FY26 results via ScanX]. Q1 FY2027 interest income was ₹76.44 Cr of ₹76.86 Cr revenue [Src: Chola Securities news feed; Whalesbook]. Fee, processing and lease-rental income are small and not separately broken out in the sources reviewed. There is no product, subscription or licensing revenue.
Funding model: Wholesale funded. Total borrowings were ₹1,550.99 Cr at a cost of 11.17% in Q1 FY2027 [Src: Q1 FY27 funding slide via Multibagg]. Sources include term loans from public and private banks (SBI, ICICI Bank, Union Bank of India and others), IREDA, AU Small Finance Bank, Kotak Mahindra Investments, NCDs (domestic, including the Wint Wealth platform), USD-denominated bonds and notes listed on India INX/Global Securities Market, a US DFC 10-year loan, BlueOrchard debt, and securitisation via PTC trusts rated by CRISIL ("MediClaim Trust 2026", "Astral Trust 2026").
Value chain position: Last-mile credit originator. In mediclaim, MGFL sits between insurer and policyholder at the point of sale, embedded in insurer or distributor journeys. In EV, it originates through OEMs, dealers and fleet operators using a "phygital" model of digital underwriting plus in-house field sales and collections. In Salary Saathi, it relies on employer or government payroll arrangements; an Assam government empanelment was announced and then clarified in March 2026.
Customer types: (i) retail insurance policyholders; (ii) drivers and owners of e-rickshaws and electric 2W/3W, often in rural and semi-urban areas; (iii) EV fleet operators, OEMs, dealers and charging/battery-swap operators; (iv) MSMEs and corporates; (v) salaried government and PSU employees.
End-markets: Indian retail health-insurance distribution; Indian EV and clean-energy ecosystem; MSME credit; payroll-linked consumer credit.
The company's own description (paraphrased from FY2026 Annual Report and May 2026 investor presentation)
The company describes itself as India's first listed EV and mediclaim-financing NBFC. Its stated aims are to advance green mobility, renewable energy, financial protection and inclusive credit access. It says it has evolved from a pure climate financier into an ecosystem-enabled lender combining technology, sector-focused underwriting and a widening product range: mediclaim premium financing, salary-linked loans to government employees, and EV/clean-energy loans [Src: FY2026 Annual Report cover letter, NSE 5 Sep 2026; Investor Presentation 25 May 2026].
Independent characterisation
Since FY2026, MGFL is best described as a digital consumer-and-MSME lender with a legacy climate-finance book, not a "green NBFC." Three structural facts support this:
-
Mediclaim financing grew from essentially nil to 39% of AUM by March 2026 and 42% by June 2026. Management targets 50–60% in FY2027 [Src: Q4 FY26 call transcript, 4 Jun 2026].
-
The climate book's share fell to ~26% of AUM by Q1 FY2027, although its absolute size remained roughly ₹400–460 Cr.
-
Operating leverage is the core thesis. FY2026 Q4 opex was flat YoY at ~₹10.4 Cr while AUM rose 84% [Src: FY26 press release via Agro Spectrum].
The "Green" in the name is now partly legacy branding. Mediclaim premium financing is short-tenor and relies on insurer-linked collections; its credit history at MGFL spans less than two years.
Strategy
Stated strategy (themes from FY2026 Annual Report, May 2026 presentation and Q4/Q1 calls, paraphrased)
-
Product-led, tech-first lending: Concentrate growth in digital, branchless products (mediclaim premium financing and Salary Saathi) that management says carry high spreads and minimal delinquency.
-
Ecosystem-enabled finance: Embed credit in partner journeys: insurers (10+ integrated), government payroll systems, EV OEMs and dealers, solar installers.
-
Operating leverage: Keep opex flat while scaling AUM; cut headcount toward ~300.
-
Funding diversification and cost reduction: Widen the lender base (PSU banks, NCD platforms, securitisation, ECB and offshore bonds, DFIs) and plan green bond issuance, leveraging the A- rating.
-
Responsible growth and asset quality: Lower GNPA (1.94% → 1.91%) and Stage 2 (12.6% → 5.9%); keep collection efficiency above 96.5%.
Strategic initiatives in the last 24 months (Oct 2024 – Oct 2026)
| Date | Initiative | Detail | Source |
|---|---|---|---|
| Jan 2025 | DFC 10-year US$18M loan | Long-tenor funding for EV and solar finance | YourStory, Jan 2025 |
| Mar 2025 | LKP Finance majority stake (group) | Capital base and Western India presence; later turned toward payments/rewards (Gyftr) | Energetica, Mar 2025 |
| FY2026 | Launch and scale of Mediclaim Premium Financing | 0 → ₹608 Cr AUM by Mar 2026 | Q4 FY26 call |
| FY2026 | Launch of Salary Saathi | ₹31 Cr (computed) → ₹53 Cr AUM by Jun 2026 | Presentations |
| Mar 2026 | Assam government empanelment (Salary Saathi) | Press release 1 Mar 2026; clarification 3 Mar 2026 | IndiaIPO / ScanX |
| Mar 2026 | ₹324 Cr preferential equity and warrants | Growth capital; CRAR to 32% | Allotment filing |
| FY2026 | Workforce rationalisation | −15.83% headcount over four quarters | Q4 FY26 presentation |
| FY2026–27 | Securitisation programme | CRISIL-rated PTCs: MediClaim Trust 2026 (Mar/May 2026), Astral Trust 2026 (Jul/Sep 2026) | Screener credit-rating links |
| Jul 2026 | ECB / foreign-currency bonds up to US$6M | Board approval 14 Jul 2026; notes listed on India INX 22 Sep 2026 | Sahi; ScanX |
| FY2026–27 | Green bond plan | Referenced in FY26 funding commentary; size n/d | Multibagg summary of FY26 presentation |
| Oct 2026 | ESOP allotments | Shares allotted on exercise, 13 Oct 2026 | BSE announcement |
Management guidance and medium-term targets
| Guidance item | FY2027 target | Source |
|---|---|---|
| AUM (INR Cr) | 2,500 | FY26 call / ScanX |
| PAT (INR Cr) | 80 to 90 | FY26 call / ScanX |
| Mediclaim share of AUM (%) | 50 to 60 | Q4 FY26 call transcript |
| Headcount (number) | ~300 | Tickertape summary |
ESG or sustainability targets with dates are not publicly disclosed. No formal cost programme target exists beyond the headcount goal.
Analyst arithmetic on guidance: Q1 FY2027 PAT of ₹14.0 Cr annualises to ~₹56 Cr. Reaching ₹80–90 Cr implies an average of ~₹22–25 Cr per quarter over Q2–Q4, i.e., a 60–80% step-up from the Q1 run rate. AUM must grow ~56% over FY2027 (₹1,599 Cr → ₹2,500 Cr in nine months, ~₹100 Cr per month).
Products & Services
Flagship offerings: Mediclaim Financing (largest and highest-growth); Climate Financing (legacy franchise and brand identity); Salary Saathi (emerging, high-quality payroll credit). Ticket sizes, tenors, interest-rate bands and fees by product are not publicly disclosed in the sources reviewed.
Product Portfolio
| # | Product / offering | Vertical | Description & key features (as disclosed) | Target customer | Launch / latest | Pricing |
|---|---|---|---|---|---|---|
| 1 | Mediclaim Premium Financing (insurance-premium EMI) | Mediclaim | Converts annual health-insurance premiums into monthly EMIs at the point of sale. Paperless and instant; integrated with 10+ insurers. Management says no branches or manpower are needed and NPA is "almost negligible" | Retail health-insurance buyers | Scaled during FY2026; 39% of AUM by Mar-26 | n/d; management cites a spread above 7–8% |
| 2 | Salary Saathi | Salary Saathi | Payroll-linked personal loans for government and PSU employees, repaid through salary deduction. Assam government empanelment announced 1 Mar 2026 and clarified 3 Mar 2026 | Government/PSU employees | FY2026 | — |
| 3 | E-rickshaw / e-3W loans | Climate | The original Mufin product since 2016: income-generating vehicle loans for drivers, largely rural and semi-urban | Individual drivers, owner-operators | 2016 (group); in MGFL since 2022 | — |
| 4 | Electric 2W loans | Climate | Retail EV loans through OEM and dealer tie-ups | Individuals, delivery riders | 2022–23 | — |
| 5 | Electric 4W / LCV / bus financing | Climate | Announced extension into buses, LCVs and commercial 4W (Feb 2024) | Fleet operators | 2,024 | — |
| 6 | Swappable / non-swappable battery financing and leasing | Climate | Loans and leases for battery packs; supports battery-as-a-service | Fleet and swap operators | 2,022 | — |
| 7 | EV charger / charging-infrastructure finance | Climate | Loans for chargers and charging stations | CPOs, dealers, businesses | 2,022 | — |
| 8 | Top-up loans for existing EV customers | Climate | Additional credit lines on performing loans | Existing borrowers | 2,022 | — |
| 9 | Solar asset financing (commercial and industrial) | Climate | Rooftop and asset finance for hotels, hospitals, offices and factories | C&I customers | 2024–25 | — |
| 10 | Solar ecosystem finance | Climate | Working capital for solar projects; individual, group and captive PPA financing; supply-chain finance across OEMs, distributors and installers | Developers, installers, OEMs | 2,025 | — |
| 11 | Dealer / OEM supply-chain and working-capital finance | Climate / MSME | Term loans, working capital, supply-chain finance and lease structures for the EV value chain | OEMs, dealers | 2023–24 | — |
| 12 | MSME & corporate secured loans ("Other Loans") | MSME | Collateral-backed term and working-capital loans; management says 100% collateral-backed | MSMEs, mid-corporates | FY2025 | — |
| 13 | Leasing (via Mufin Green Leasing Pvt Ltd) | Climate | Operating/finance lease of EV assets | Fleets | 2,023 | — |
| 14 | Green infrastructure (via Mufin Green Infra Ltd, 65%) | Climate | Purpose not detailed in reviewed sources | — | 2,024 | — |
Financial Narrative
Basis: Standalone Ind AS figures as compiled by Screener.in/C-MOTS from audited annual results, rounded to ₹ Cr, cross-checked with company releases where available. FY2023–FY2026 reflect the post-acquisition lending business; FY2022 still reflects the legacy investment company. NBFC accounting means "gross profit", "EBITDA" and "capex" are not standard concepts; NBFC equivalents (net interest income, pre-provision operating profit) are used and labelled.
Income statement (₹ Cr, standalone)
Sources: Screener.in standalone P&L FY2022–FY2026. FY2023/FY2024 revenue and PAT from the company's FY2024 results (Goodreturns, May 2024). FY2026 revenue (₹210.29 Cr) and PAT (₹28.21 Cr, +39.1% YoY) from FY26 results (ScanX). FY2025 PAT of ₹20.28 Cr is computed from ₹28.21 Cr ÷ 1.391; Chola Securities reports ₹19.61 Cr for FY2025, likely the consolidated figure (discrepancy noted). Aggregator EPS is shown as reported and may not be fully restated for the 2:1 bonus and later issuances; diluted EPS is not publicly disclosed in the reviewed sources. Screener records a 4% dividend payout for FY2022 (legacy APM era); no dividends since.
Margins and growth (computed)
Revenue CAGR FY2022–FY2026 (4 years): ~94% (computed from ₹15 Cr to ₹210.29 Cr). Revenue CAGR FY2023–FY2026 (3 years): ~83% (computed; matches Screener's 83%).
The company's own cost-to-income ratio is 45.8% for FY2026 (47.5% in Q4 FY2025) [Src: Q4 FY26 presentation]. This differs from the computed proxy above because of different treatment of provisions and other income.
Balance sheet (₹ Cr, standalone, 31 March)
Sources: Screener.in standalone balance sheet. Loans for FY2023 (₹25,853.45 lakh) and FY2024 (₹61,929.57 lakh) from the audited Statement of Assets and Liabilities (NSE filing, 28 May 2024). AUM from investor presentations. The short-term / long-term debt split, cash and equivalents, and working capital are not publicly disclosed in the aggregator data reviewed. Working capital is not a meaningful NBFC metric. Goodwill/intangibles are shown as nil because none appear in aggregator data; this should be verified against the annual report.
Net debt: Cash balances are not disclosed in the sources reviewed, so net debt cannot be computed. Gross borrowings were ₹1,398 Cr at FY2026 (standalone balance sheet) and ₹1,550.99 Cr at 30 June 2026 (company funding slide).
Cash flow (₹ Cr, standalone)
Source: Screener.in. For a lender, negative operating cash flow mainly reflects loan-book growth (loans are operating assets), not operating losses. FCF is therefore not a meaningful metric. Capex is minimal (fixed assets ₹6–9 Cr).
Ratios (computed unless stated)
Sources: CRAR from ScanX (5 Sep 2026, FY2026). GNPA/NNPA from FY26 press release and ICICI Direct (NNPA 1.65% vs 2.12%; GNPA 1.94% vs 2.48–2.50%). Stage 2 from Q4 FY26 presentation. Company ROE/ROA from Q4 FY26 presentation. Current ratio, ROIC, net debt/EBITDA and cash conversion cycle are not meaningful for an NBFC and are omitted. Q1 FY2027: GNPA 1.91%; cost of borrowings 11.17%, down 263 bps YoY from 13.80% [Src: Q1 FY27 update; ScanX].
Quarterly trajectory (₹ Cr, standalone)
Sources: Screener quarterly (rounded); Q4 FY2026 revenue and PAT from MarketsMojo/ICICI Direct (consolidated ₹64.67 Cr / ₹11.09 Cr); Q1 FY2027 from Whalesbook/Multibagg; AUM and disbursements from the Q4 FY26 call transcript. Q1 FY2027 disbursements total is not stated in the reviewed sources; mediclaim alone was ₹247.08 Cr, and one summary cites ₹449 Cr of quarterly disbursements (+37.3%) but with an inconsistent AUM reference, so it is not used. Q1 FY2026 PAT is ₹3.14 Cr consolidated (company presentation); one source cites ₹4.1 Cr standalone (discrepancy).
Commentary on trends, inflections and drivers
Phase 1 — Investment shell (FY2017–FY2022). Under APM ownership the company held a listed-equity investment portfolio of ₹59–73 Cr with no borrowings. Earnings tracked mark-to-market swings: a ₹6 Cr loss in FY2020 and a ₹20 Cr profit in FY2021. In FY2022, investments fell from ₹73 Cr to ₹10 Cr and "other assets" (loans) rose to ₹91 Cr. This was the liquidation of the legacy portfolio around the change of control and its redeployment into lending.
Phase 2 — Leveraged EV-lending build-out (FY2023–FY2025). Borrowings rose from nil to ₹704 Cr and leverage from 0x to ~2.6x. NII rose from ₹28 Cr to ₹71 Cr, but the NII/revenue ratio collapsed from 81% to 44%. Funding costs were high at 13–14%, reflecting a BBB-rated issuer funded by NCDs, DFIs and small banks. ROA compressed from ~3.3% to ~2.1%. Asset quality in EV lending was mediocre: Stage 2 at 12.6% and GNPA ~2.5% at FY2025. PAT grew more slowly than revenue (FY2025 PAT +26% vs revenue +65%).
Phase 3 — Pivot and re-rating of funding (FY2026–Q1 FY2027). Three drivers changed together:
Product mix shift: to digital mediclaim and payroll loans.
Funding-cost decline: after Acuité's April 2025 upgrade to A-: cost of borrowings fell from 13.80% (Q1 FY2026) to 11.17% (Q1 FY2027), with Union Bank of India and Wint Wealth NCD lines added.
Operating leverage: Q4 opex flat YoY; Q1 FY2027 opex down 17.2% YoY to ₹13.55 Cr per company release.
The result was a sharp quarterly PAT inflection: ₹3.1 Cr in Q1 FY2026 to ₹14.0 Cr in Q1 FY2027. The ₹324 Cr preferential raise in March 2026 more than doubled net worth to ₹575 Cr, cutting leverage to ~2.4x and lifting CRAR to 32%. That will dilute ROE in FY2027 until the capital is deployed.
Data anomaly: One release reports Q1 FY2027 "pre-provisioning operating profit" of ₹62.98 Cr (+102% YoY) [Src: SolarQuarter, 13 Aug 2026]. This is arithmetically inconsistent with revenue of ₹76.86 Cr and finance cost of ~₹41 Cr, and likely mislabels gross interest income net of some item or NII. It should not be relied on.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Group Entities
| Entity | Relationship | Ownership | Incorporated | Function (as disclosed) |
|---|---|---|---|---|
Hindon Mercantile Ltd | Parent / promoter | Holds controlling block with Kapil Garg family; promoter group total 47.30% (Jun 2026) | — | Mufin Group holding NBFC; original e-rickshaw financier |
Mufin Green Finance Ltd | Listed entity | — | 13 May 2016 | NBFC-ND lender |
Mufin Green Leasing Pvt Ltd | Subsidiary | 100% | 8 Aug 2023 | Leasing (EV/battery assets; inferred from name) |
Mufin Green Infra Ltd | Subsidiary | 65% | 2 Mar 2024 | Green infrastructure (charging/solar; inferred) |
LKP Finance Ltd (proposed rename "Gyftr") | Group company under common control | Majority acquired by "Mufin Group" in Mar–Apr 2025. Whether MGFL itself or the promoter group holds the stake is not clearly disclosed | — | Surrendering NBFC licence; holds 22% of Mufin Pay, which owns Gyftr (Vouchagram) |
Mufin Pay | Group company | — | — | RBI-licensed PPI/wallet/UPI infrastructure |
Bimapay Finsure Pvt Ltd | Kapil Garg directorship | — | — | — |
Revenue by Segment
| Vertical AUM (INR Cr) | FY2025 | FY2026 | Q1FY2027 |
|---|---|---|---|
Mediclaim Financing | — | 607.88 | 676.61 |
Climate Financing EV and Solar | — | 462.35 | 410.83 |
Other Loans MSME and Corporate | — | 446.94 | 458.84 |
Salary Saathi | — | 30.82 | 52.97 |
Total AUM | 838.44 | 1,541.17 | 1,599.23 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansVertical share of AUM (%)
| Vertical share of AUM (%) | FY2026 | Q1FY2027 |
|---|---|---|
Mediclaim Financing | 39 | 42 |
Climate Financing EV and Solar | 30 | 26 |
Other Loans MSME | 29 | 29 |
Salary Saathi | 2 | 3 |
Revenue by Segment and Operating Metrics (number)
| Metric | Q1FY2026 | Q1FY2027 | YoY % |
|---|---|---|---|
Mediclaim disbursements (INR Cr) | 158.18 | 247.08 | 56.2 |
Mediclaim disbursement count (number) | 32,500 | 48,214 | 48.4 |
Income Statement and Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue from operations (INR Cr) | 15 | 34.43 | 97.70 | 160.96 | 210.29 |
Finance cost interest expense (INR Cr) | 0 | 6 | 45 | 90 | 120 |
Net interest income proxy revenue minus finance cost (INR Cr) | 15 | 28 | 53 | 71 | 90 |
Operating expenses incl provisions (INR Cr) | 2 | 16 | 29 | 42 | 50 |
Depreciation (INR Cr) | 0 | 2 | 2 | 3 | 3 |
Profit before tax (INR Cr) | 13 | 11 | 21 | 27 | 38 |
Tax rate (%) | 14 | 25 | 24 | 26 | 26 |
Net profit PAT (INR Cr) | 11 | 8.12 | 16.06 | 20.28 | 28.21 |
EPS basic as reported by aggregator (INR) | 0.84 | 0.54 | 0.99 | 1.24 | 1.43 |
Dividend per share (INR) | 0 | 0 | 0 | 0 | 0 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansMargin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
NII as percent of revenue (%) | 100 | 81 | 54 | 44 | 43 |
Cost to income opex over NII (%) | 13 | 57 | 55 | 59 | 56 |
PBT margin (%) | 87 | 32 | 21 | 17 | 18 |
Net margin PAT over revenue (%) | 73 | 24 | 16 | 13 | 13 |
Revenue growth YoY (%) | -35 | 130 | 184 | 65 | 31 |
PAT growth YoY (%) | -45 | -26 | 98 | 26 | 39 |
Balance Sheet
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total assets (INR Cr) | 103 | 395 | 926 | 1,021 | 2,028 |
Loans net (INR Cr) | — | 258.53 | 619.30 | — | — |
AUM reported (INR Cr) | — | — | — | 838.44 | 1,541.17 |
Investments (INR Cr) | 10 | 3 | 5 | 5 | 165 |
Fixed assets (INR Cr) | 2 | 3 | 9 | 6 | 7 |
Equity share capital (INR Cr) | 4 | 5 | 16 | 16 | 20 |
Reserves (INR Cr) | 97 | 149 | 228 | 254 | 555 |
Net worth (INR Cr) | 101 | 154 | 244 | 270 | 575 |
Total borrowings (INR Cr) | 0 | 226 | 640 | 704 | 1,398 |
Other liabilities (INR Cr) | 1 | 16 | 41 | 47 | 55 |
Goodwill and intangibles (INR Cr) | 0 | 0 | 0 | 0 | 0 |
Cash Flow
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Cash from operating activities (INR Cr) | -58 | -175 | -359 | -142 | -695 |
Cash from investing activities (INR Cr) | 67 | -85 | -57 | 90 | -173 |
Cash from financing activities (INR Cr) | 0 | 269 | 486 | 56 | 925 |
Net cash flow (INR Cr) | 9 | 8 | 70 | 4 | 57 |
Free cash flow aggregator definition (INR Cr) | -60 | -175 | -361 | -143 | -699 |
Dividends paid (INR Cr) | 0 | 0 | 0 | 0 | 0 |
Buybacks (INR Cr) | 0 | 0 | 0 | 0 | 0 |
Margin Analysis (%) and Financial Ratios (x)
| Ratio | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
ROE reported by Screener (%) | 11 | 6 | 8 | 8 | 7 |
ROE company reported weighted (%) | — | — | — | — | 8.82 |
ROA on average total assets (%) | 11.2 | 3.3 | 2.4 | 2.1 | 1.9 |
ROA company reported weighted (%) | — | — | — | — | 2.31 |
Debt to equity (x) | 0.00 | 1.47 | 2.62 | 2.61 | 2.43 |
Interest coverage PBT plus interest over interest (x) | — | 2.8 | 1.5 | 1.3 | 1.3 |
Asset turnover revenue over average assets (x) | 0.15 | 0.14 | 0.15 | 0.17 | 0.14 |
Capital adequacy CRAR (%) | — | — | — | — | 32.08 |
Gross NPA (%) | — | — | — | 2.48 | 1.94 |
Net NPA (%) | — | — | — | 2.11 | 1.65 |
Stage 2 assets (%) | — | — | — | 12.60 | 5.90 |
Cost of borrowings Q4 (%) | — | — | — | — | 12.17 |
Income Statement
| Metric | Q1FY2026 | Q2FY2026 | Q3FY2026 | Q4FY2026 | Q1FY2027 |
|---|---|---|---|---|---|
Revenue (INR Cr) | 48 | 51 | 53 | 64.67 | 76.86 |
Finance cost (INR Cr) | 25 | 26 | 31 | 38 | 41 |
Operating expenses (INR Cr) | 17 | 17 | 12 | 12 | 16 |
Profit before tax (INR Cr) | 6 | 8 | 9 | 15 | 18.82 |
Net profit (INR Cr) | 3.14 | 6 | 7 | 11.09 | 14.01 |
AUM (INR Cr) | 944 | 1,028 | 1,156 | 1,541.17 | 1,599.23 |
Disbursements (INR Cr) | 322 | 360 | 387 | 699.91 | — |
Region revenue (INR Cr)
| Region revenue (INR Cr) | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
India | 97.70 | 160.96 | 210.29 |
Outside India | 0 | 0 | 0 |
Operating Metrics (number)
| Metric | FY2024 | FY2025 |
|---|---|---|
States and UTs of presence (number) | 16 | 26 |
Valuation Snapshot
| Metric | Value | Source |
|---|---|---|
Price (19 Oct 2026 close) | ₹141 | Screener.in |
Market cap | ~₹2,797 Cr | Screener.in |
52-week high / low | ₹144 / ₹94.1 | Screener.in |
1-year return | ~43% | Screener (stock price CAGR) |
3-year CAGR | ~12% | Screener |
5-year CAGR | ~92% | Screener |
Beta | ~0.88 (legacy listing data) | Snowball Analytics |
Price point (INR) | Date | Source |
| 61.60 | 28 Jan 2022 (pre-split, ₹2 FV) | Equity Bulls |
| 129.30 | 3 Nov 2023 (NSE listing approval) | Business Today |
| 69.66 | 8 May 2025 | IIFL |
| 107.50 | 8 Dec 2025 | Kotak Securities |
| 116.65 | 22 Apr 2026 | Kotak Neo |
| 133.86 | 30 Jun 2026 | Bajaj Finserv |
| 143.90 | 12 Aug 2026 (52-week high) | Whalesbook |
| 141.00 | 19 Oct 2026 | Screener |
Valuation Multiples
| Multiple | Mufin Green Finance | Peer reference |
|---|---|---|
P/E trailing (x) | 73.3 | Aye Finance 17.7 (May 2026) |
P/B (x) | 4.86 | Aye Finance 1.35; peer average <1 (May 2026) |
Market cap / revenue TTM (x) | 11.4 | — |
P/E on FY2027 guidance midpoint ₹85 Cr (x) | 32.9 | computed; dilution from warrants ignored |
EV/EBITDA | Not meaningful for an NBFC | — |
Share Price & Returns
| Date | Instrument | Size | Price |
|---|---|---|---|
FY2024 (Series B) | Preferential shares / warrants | ₹140 Cr | — |
Nov 2023 – early 2024 | 2:1 bonus | — | — |
25 Jan & 8 Feb 2024 | Warrant conversions (27.4 lakh and 45.6 lakh shares) | — | — |
Date n/d | Warrant conversion (36.25 lakh warrants) | ₹14.95 Cr | ~₹41 per share (computed) |
4 Mar 2026 | Preferential equity + warrants | ₹324 Cr | ₹98 |
13 Oct 2026 | ESOP allotment | — | — |
Analyst Ratings & Targets
| Date | Agency | Instrument | Rating / outlook |
|---|---|---|---|
10 Aug 2023 | Acuité | ₹60 Cr NCD, ₹100 Cr bank lines, bond | BBB / Stable |
28 Dec 2023 | Acuité | NCDs (₹90 Cr new + ₹60 Cr), bank lines | BBB / Stable |
30 May 2024 | Acuité | ₹150 Cr NCD, ₹250 Cr bank lines, bond | BBB / Positive |
6 Jun 2024 | Acuité | ₹150 Cr NCD, bank lines (₹270 Cr), bond | Upgraded to BBB+ / Stable |
7 Apr 2025 | Acuité | NCD, bond (₹100 Cr), bank lines | BBB+ / Stable (reaffirmed) |
17 Apr 2025 | Acuité | Same | Upgraded to A- / Stable (consolidated with Hindon Mercantile) |
4 Sep 2025 | Acuité | ₹100 Cr new NCD (₹200 Cr reaffirmed) | A- / Stable |
Mar – Sep 2026 | CRISIL | PTCs: MediClaim Trust 2026, Astral Trust 2026 | Structured-finance ratings (levels n/d) |
Capital Instruments
| Instrument | Amount | Coupon | Tenor / maturity |
|---|---|---|---|
DFC loan | US$18M | — | 10 years (from Jan 2025) |
USD bonds (Global Securities Market) | US$5M | — | — |
NCDs allotted 11 Feb 2026 | ₹100 Cr | 11% (reported) | — |
NCDs allotted 15 Jun 2026 | ₹19 Cr | — | — |
NCDs allotted 21 Jul 2026 | ₹55 Cr | 10% | 15 months (Oct 2027) |
NCDs Aug 2026 | ₹50 Cr and ₹75 Cr | — | — |
ECB notes (India INX) | US$6M | — | — |
Wint Wealth NCD facility | ₹100 Cr | — | — |
Union Bank of India term loan | ₹25 Cr | — | — |
Analyst Conclusions
Management guidance (FY2027)
AUM ~₹2,500 Cr (+62% vs FY2026); PAT ₹80–90 Cr (~3x FY2026); mediclaim at 50–60% of AUM; continued cost-of-funds reduction; headcount toward ~300.
Consensus
None available (no sell-side coverage).
Bull case
-
Operating leverage is real and visible. Q1 FY2027 revenue grew 60% while opex fell 17%, and PAT rose from ₹3.1 Cr to ₹14.0 Cr YoY. If the digital mix reaches 55–60%, NII flows disproportionately to PAT and ROE could move from ~7% toward the low teens.
-
Funding cost tailwind compounds. A 263 bps YoY fall in cost of funds to 11.17%, an A- rating, new PSU-bank lines and coupons now at 10% suggest further repricing as older 13–14% debt runs off, especially if a further upgrade follows.
-
Balance sheet de-risked for growth. CRAR of 32% and net worth of ₹575 Cr can support ₹2,500 Cr+ AUM without fresh equity, and asset quality is improving (Stage 2 down from 12.6% to 5.9%).
Bear case
-
Credit risk is untested. Mediclaim and Salary Saathi have not been through a full cycle. Low early NPAs in a fast-growing book are partly an arithmetic artefact ("denominator effect"), and losses could surface in FY2028.
-
Valuation already discounts success. At ~4.9x book and ~73x trailing earnings vs NBFC peers near 1–1.5x book, even hitting the ₹80–90 Cr guidance implies ~33x forward P/E. Any miss on the ~60–80% quarterly PAT step-up needed in Q2–Q4 could de-rate the stock sharply.
-
Governance and related-party complexity. Promoter-MD control, four material RPTs, intertwined group fintechs, an auditor resignation and a press-release clarification add disclosure risk. Promoter holding fell below 50%.
Catalysts and monitorables (next 12 months)
| Catalyst / monitorable | Timing | What to watch |
|---|---|---|
| Q2 FY2027 results | ~early–mid Nov 2026 | PAT run rate vs ~₹22–25 Cr/quarter needed; AUM vs ₹2,500 Cr path; GNPA |
| Mediclaim book seasoning | Quarterly | 30+/90+ DPD, insurer concentration, securitisation performance (CRISIL PTC surveillance) |
| Acuité annual review | ~Apr–Sep 2027 (Sep 2025 rating valid to 25 Aug 2026; renewal status to confirm) | Potential A / Stable upgrade |
| Promoter warrant conversion | Within 18 months of Mar 2026 | ₹75 Cr inflow (76.5 lakh × ₹98, computed balance due) and promoter stake recovery |
| Climate book run-off | Quarterly | Collections on the shrinking EV book; DFI covenant compliance |
| Related-party transactions | Ongoing | Flows with Mufin Pay, LKP/Gyftr, Bimapay, Hindon Mercantile |
| Regulatory | Ongoing | RBI digital-lending and consumer-credit norms; IRDAI premium-instalment rules |
| Q4 FY2027 / FY2027 results | ~May 2027 | Delivery vs ₹80–90 Cr PAT guidance |
Analyst verdict
APM Finvest has ceased to exist in any meaningful sense except as a legal shell. The listed company is now Mufin Green Finance, a promoter-led, wholesale-funded NBFC in the middle of a second reinvention: from investment holding company to EV lender (2022–2025), and now from EV lender to digital consumer financier (2025 onward). The latest data are strong. Q1 FY2027 PAT more than quadrupled YoY to ₹14 Cr, AUM grew 69% to ₹1,599 Cr, cost of funds fell 263 bps, GNPA is below 2%, and a ₹324 Cr equity raise pushed CRAR to 32%. Few Indian small-cap NBFCs combine that much growth, an improving rating trajectory and visible operating leverage.
Three questions remain open. The first is credit quality: the mediclaim and payroll books that now drive the story are too young to judge, and premium financing depends on a handful of insurer relationships whose terms are not disclosed. The second is scale versus guidance: ₹80–90 Cr PAT for FY2027 requires roughly a 60–80% step-up from the Q1 run rate in the remaining three quarters, while AUM must grow by about ₹100 Cr a month. The third is governance: an auditor resignation, a corrected press release, material related-party transactions and a dense web of group fintech entities call for a higher disclosure standard than the company currently meets.
On valuation, the market already prices in substantial success. At roughly 4.9x book and 33x guided forward earnings (before warrant dilution), the stock carries limited margin of safety against an execution or credit stumble.
Net view: fundamentally improving, but speculative at current prices. Suitable as a monitored position, sized for high volatility, with Q2 and Q3 FY2027 delivery against guidance and the first full-cycle mediclaim delinquency data as the decisive tests. Not institutional-core until coverage, disclosure depth and an independent rating at A or above are established.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Tenure | Background / education | Age | FY compensation |
|---|---|---|---|---|---|
Kapil Garg | Promoter, Managing Director (Executive Director) | Board since 9 Mar 2022 | Co-founder of Mufin Group (2016). Chartered Accountant (India) and CPA (Australia). Directorships include Bimapay Finsure, Mufin Green Leasing, Mufin Green Infra | ~44 in Feb 2024 per SEBI DPS (~46–47 now) | Not publicly disclosed in reviewed sources (see AR FY2026 MGT/remuneration annexure) |
Gunjan Jain (CA) | Chief Financial Officer | Since 14 Nov 2022 | Chartered Accountant | — | — |
Mayank Pratap Singh | Company Secretary & Compliance Officer | At least May 2022 – 2024 | Company Secretary | — | — |
Dhiraj Agrawal | Chief Business Officer | — | — | — | — |
Darpan Tiwari | President, Partnerships & Alliances | — | — | — | — |
Waquar Ali Syed | VP, Collection & Strategy | — | — | — | — |
Pankaj Gupta | CEO (named Aug 2022) | Current status not confirmed | — | — | — |
Rajat Goyal | Co-founder, Mufin Group | Group level | — | — | — |
Board of Directors
| Director | Category | Appointed | Committee roles (Apr 2026 governance filing) |
|---|---|---|---|
Manoj Kumar Bhatt (DIN 09452843) | Chairman, Non-Executive Independent | 9 Mar 2022 | Audit Committee member; NRC member |
Hemant Bhageria (DIN 06476292) | Non-Executive Independent | 9 Mar 2022 | Audit Committee Chair; NRC member; chair of a third committee (likely Stakeholders Relationship) |
Nitin Goel (DIN 01737352) | Non-Executive Independent | 9 Mar 2022 | NRC Chair; member of another committee |
Kapil Garg (DIN 01716987) | Managing Director (Executive) | 9 Mar 2022 | Audit Committee member |
Sanchi Pandey (DIN 08210470) | Independent Director (woman director) | By FY2025 | — |
Srishti Agarwal (DIN 10229578) | Non-Executive Non-Independent | 11 Aug 2023 | — |
Luv Khanna | Director (per third-party database) | — | — |
Shareholding Trend
| Holder category (%) | Mar2023 | Mar2024 | Mar2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|
Promoters | 58.19 | 54.77 | 54.31 | 47.30 | 47.30 |
FIIs | 0.00 | 0.11 | 1.25 | 1.18 | 2.26 |
DIIs | 14.12 | 13.16 | 12.53 | 9.29 | 10.05 |
Public | 27.69 | 31.96 | 31.92 | 42.22 | 40.39 |
Number of shareholders | 10,521 | 22,133 | 25,971 | 25,767 | 24,964 |
Major Shareholders
| Holder | Type | Stake |
|---|---|---|
Hindon Mercantile Ltd | Promoter (parent) | Majority of the promoter group's 47.30%; exact split n/d |
Kapil Garg | Promoter | 16,40,000 shares (0.83%) [Src: Bajaj Finserv shareholding page, 2026] |
Pooja Garg | Promoter group | — |
SageOne Investments (fund/AIF) | Preferential investor, Mar 2026 | — |
Sandeep Kapadia | Preferential investor, Mar 2026 | — |
DS Group | Preferential investor, Mar 2026 | — |
MMG family office | Preferential investor, Mar 2026 | — |
Competitive Landscape
Competitors by Segment
| Vertical | Named competitors | Notes |
|---|---|---|
EV / climate finance | Revfin, Vidyut, Three Wheels United, OTO Capital, Ecofy, Hero FinCorp, evfin, Finayo, Bajaj Finance and bank captives (2W EV) | Revfin raised a US$14M Series B (Omidyar) in early 2024; most specialists are unlisted [Src: Entrackr, Mar 2024] |
Insurance-premium / health EMI finance | Bajaj Finance (EMI network), insurer-partnered BNPL/fintech NBFCs, credit-card EMI by banks | No listed pure-play peer identified |
Payroll / salary-linked loans | Kinara/Fibe-type salaried lenders, PSU banks' personal loans, NBFC personal-loan apps | — |
MSME secured loans | UGRO Capital, Aye Finance, Arman Financial, Moneyboxx, Paisalo Digital | Listed small/mid-cap NBFCs |
Listed small NBFC comparables | Apollo Finvest (NBFC-as-a-service), Aye Finance, UGRO Capital, Paisalo Digital | Used for valuation context |
Peer Comparison FY2026
| Metric | Mufin Green Finance | Apollo Finvest | Aye Finance |
|---|---|---|---|
Revenue FY2026 (INR Cr) | 210.29 | 20.7 | — |
PAT FY2026 (INR Cr) | 28.21 | 6.96 | — |
P/E May 2026 (x) | 106.13 | — | 17.67 |
P/B May 2026 (x) | 6.63 | — | 1.35 |



